FindTrial
Sign In

to study the effectiveness of propofol administered at the end of the surgery for prevention of emergence agitation in children undergoing adenotonsillectomy

A randomized controlled study to evaluate effectiveness of propofol administered at the end of the surgery for prevention of emergence agitation in children undergoing adenotonsillectomy in department of anaesthesia, SMS Medical College, Jaipur. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071825
Enrollment
70
Registered
2024-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J353- Hypertrophy of tonsils with hypertrophy of adenoids

Interventions

Intervention1: injection propofol 1mg per kg: Single dose of injection propofol 1 mg per kg administered intravenously intra operatively at the end of the adenotonsillectomy and will be observed for e

Sponsors

Department of anaesthesia Sawai Man Singh Medical College JLN marg Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All elective ASA I & II paediatric patients of either sex, age between 3-10 years undergoing adenotonsillectomy under general anaesthesia. 2. Patient’s parents willing to give consent.

Exclusion criteria

Exclusion criteria: 1. Patients part of any other study. 2. Non co-operative patient. 3. Patient with known allergy to propofol. 4. Patient with known psychiatric disorder. 5. Patients having upper respiratory tract infection. 6. Patient requiring intra operative propofol for any indication

Design outcomes

Primary

MeasureTime frame
To determine and compare the incidence (WATCHA scale) and severity (PAED scale) of emergence agitation in both study and control group.Timepoint: 5 minute, 10 minute, 15 minute—

Secondary

MeasureTime frame
1. To determine and compare the emergence time between two groups. 2. To determine side effects and complication if any.Timepoint: 5 minute, 10 minute, 15 minute—

Countries

India

Contacts

Public ContactDr Premal Panchal

Sawai Man Singh Medical College

drmamtasharma@hotmail.com9829566077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026